ALLISON DIXON: Open Payments
NPI 1851160261 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $131 |
| Medicure Pharma Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $118 |
| Boston Scientific Corporation | 1 | $21 |
| Solventum Corporation | 1 | $21 |
Products named: INGREZZA, Zypitamag, Biktarvy, General - Pain Management, V.A.C. VERAFLO CLEANSE CHOICE.
Industry payments across GA — which companies pay providers there.
